| Document and Entity Information | Mar. 24, 2022 |
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001831828 |
| Document Type | 8-K |
| Document Period End Date | Mar. 24, 2022 |
| Entity Registrant Name | Vera Therapeutics, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-40407 |
| Entity Tax Identification Number | 81-2744449 |
| Entity Address, Address Line One | 8000 Marina Boulevard |
| Entity Address, Address Line Two | Suite 120 |
| Entity Address, City or Town | Brisbane |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94005 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Class A common stock, $0.001 par value per share |
| Trading Symbol | VERA |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
